Pfizer intends to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner
Jan 14, 2025 9:08 AM
(Reuters) - Pfizer ( PFE ) intends to sell about 700 million ordinary shares in Haleon ( HLN ), cutting its stake to about 7.3% in the British consumer healthcare group, a bookrunner said on Tuesday.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.